Novel Drug Delivery System Of Hemagglutinin Vaccine

Brilliani, Kenny Nurmalia (2021) Novel Drug Delivery System Of Hemagglutinin Vaccine. World Journal of Pharmaceutical Research, 10 (10). pp. 1378-1385. ISSN 2277– 7105

PDF Kenny_NOVEL DRUG DELIVERY SYSTEM.pdf Download (280kB)

Abstract

The influenza virus is a respiratory disease spread by coughing or sneezing from an infected person by breathing from one patient to another. The global burden of 1 billion infections and between 3 and 5 million cases of severe illness caused by influenza epidemics is projected each year. There are currently two major types of influenza vaccine available: the inactivated vaccine (monovalent and protective against the strain A (H1N1)) and the live attenuated vaccine. Then a different influenza virus was isolated (influenza B) in 1940 and the first bivalent vaccine was tested in healthy adults. Many inactive vaccines are currently being developed in embryonic chicken eggs from propagation. However, a limiting factor is the availability of embryonated chicken eggs, and global production is not expected to meet the increasing demand for doses during the pandemic season. New influenza A strains with specific HA and NA were reported in the late 1970s. Since then, in most influenza vaccines, called trivalent influenza vaccine (TIV), two influenzas A strains (H1N1 and H3N2 subtypes) and one influenza B strain have been included (l.Barberis, 2013).

Item Type:	Article
Subjects:	R Medicine > RS Pharmacy and materia medica
Divisions:	Postgraduate Programs > Master Program in Clinical Pharmacy
Depositing User:	Ester Sri W. 196039
Date Deposited:	06 Aug 2021 07:12
Last Modified:	06 Aug 2021 07:12
URI:	http://repository.ubaya.ac.id/id/eprint/39970

Actions (login required)

View Item